Literature DB >> 22882114

Stillbirth and fetal growth restriction.

C Serena1, G Marchetti, M P Rambaldi, S Ottanelli, M Di Tommaso, L Avagliano, A Pieralli, G Mello, F Mecacci.   

Abstract

OBJECTIVE: To confirm the role of fetal growth restriction (FGR) as a cause of stillbirth, and to compare diagnostic accuracy of customized fetal growth and population-based standards in identifying FGR within a pathological population of early and late stillbirths.
METHODS: Retrospective study on a cohort of 189 stillbirths occurred in single pregnancy between January 2006 and September 2011. Unexplained stillbirths, defined by Aberdeen-Wigglesworth and ReCoDe classifications, were evaluated on the basis of fetal birthweight with both Tuscany population and Gardosi customized standards. Unexplained stillbirths have been classified as early or late depending on the gestational age of occurrence.
RESULTS: Aberdeen-Wigglesworth classification, applied to the 189 cases of stillbirth, left 94 unexplained cases (49.7%), whereas the ReCoDe classification left only 40 (21%). By applying population standards to the 94 unexplained stillbirths we have identified 31 FGRs (33% of sample), while customized standards identified 54 FGRs (57%). Customised standards identified a larger number of FGRs with respect to population standards during the third trimester (i.e. 51% vs. 25% respectively) than in the second trimester (73% vs. 54% respectively) (p = 0.05).
CONCLUSIONS: Customized standards have a higher diagnostic accuracy in identifying FGRs especially during the third trimester.

Entities:  

Mesh:

Year:  2012        PMID: 22882114     DOI: 10.3109/14767058.2012.718389

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  12 in total

1.  Criteria for assigning cause of death for stillbirths and neonatal deaths in research studies in low-middle income countries.

Authors:  Robert L Goldenberg; Lulu Muhe; Sarah Saleem; Sangappa Dhaded; Shivaprasad S Goudar; Janna Patterson; Assaye Nigussie; Elizabeth M McClure
Journal:  J Matern Fetal Neonatal Med       Date:  2018-08-23

2.  A new customized fetal growth standard for African American women: the PRB/NICHD Detroit study.

Authors:  Adi L Tarca; Roberto Romero; Dereje W Gudicha; Offer Erez; Edgar Hernandez-Andrade; Lami Yeo; Gaurav Bhatti; Percy Pacora; Eli Maymon; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2018-02       Impact factor: 8.661

3.  The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Offer Erez; Adi L Tarca; Agustin Conde-Agudelo; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo; Steven J Korzeniewski
Journal:  Am J Obstet Gynecol       Date:  2017-10-13       Impact factor: 8.661

4.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

5.  Classification systems for causes of stillbirth and neonatal death, 2009-2014: an assessment of alignment with characteristics for an effective global system.

Authors:  Susannah Hopkins Leisher; Zheyi Teoh; Hanna Reinebrant; Emma Allanson; Hannah Blencowe; Jan Jaap Erwich; J Frederik Frøen; Jason Gardosi; Sanne Gordijn; A Metin Gülmezoglu; Alexander E P Heazell; Fleurisca Korteweg; Joy Lawn; Elizabeth M McClure; Robert Pattinson; Gordon C S Smith; Ӧzge Tunçalp; Aleena M Wojcieszek; Vicki Flenady
Journal:  BMC Pregnancy Childbirth       Date:  2016-09-15       Impact factor: 3.007

6.  Stillbirths at Term: Case Control Study of Risk Factors, Growth Status and Placental Histology.

Authors:  Federico Mecacci; Caterina Serena; Laura Avagliano; Mauro Cozzolino; Eleonora Baroni; Marianna Pina Rambaldi; Serena Simeone; Francesca Castiglione; Gian Luigi Taddei; Gaetano Bulfamante
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

7.  Intrapartum fetal deaths and unexpected neonatal deaths in the Republic of Ireland: 2011 - 2014; a descriptive study.

Authors:  K McNamara; K O'Donoghue; R A Greene
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-04       Impact factor: 3.007

Review 8.  Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).

Authors:  Patricia Healy; Sanne Gordijn; Wessel Ganzevoort; Irene Beune; Ahmet Baschat; Asma Khalil; Louise Kenny; Frank Bloomfield; Mandy Daly; Aris Papageorghiou; Declan Devane
Journal:  Trials       Date:  2018-08-22       Impact factor: 2.279

9.  The DESiGN trial (DEtection of Small for Gestational age Neonate), evaluating the effect of the Growth Assessment Protocol (GAP): study protocol for a randomised controlled trial.

Authors:  Matias C Vieira; Sophie Relph; Andrew Copas; Andrew Healey; Kirstie Coxon; Alessandro Alagna; Annette Briley; Mark Johnson; Deborah A Lawlor; Christoph Lees; Neil Marlow; Lesley McCowan; Louise Page; Donald Peebles; Andrew Shennan; Baskaran Thilaganathan; Asma Khalil; Jane Sandall; Dharmintra Pasupathy
Journal:  Trials       Date:  2019-03-04       Impact factor: 2.279

10.  Association between reduced stillbirth rates in England and regional uptake of accreditation training in customised fetal growth assessment.

Authors:  Jason Gardosi; Sally Giddings; Sally Clifford; Lynne Wood; André Francis
Journal:  BMJ Open       Date:  2013-12-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.